COVID-19 vaccination programme in the United Kingdom

From Wikipedia, the free encyclopedia
Jump to navigation Jump to search

GP-led vaccination centres were in operation by 15 December 2020
Distribution of the 8,369,438 total cumulative vaccine doses, as at 28 January 2021.[1][2]

The COVID-19 vaccination programme in the United Kingdom is the world's first mass immunisation campaign to protect against SARS-CoV-2 using vaccines developed in response to the COVID-19 pandemic.

Vaccinations began on 8 December 2020, shortly after the British regulator, the Medicines and Healthcare products Regulatory Agency (MHRA), granted emergency authorisation to the Pfizer–BioNTech vaccine, an RNA vaccine. On 30 December 2020, the MHRA gave approval to a second vaccine, the Oxford–AstraZeneca vaccine, and vaccinations began on 4 January 2021, with a third vaccine, the Moderna vaccine, approved on 8 January 2021.

The first two vaccines currently in use were developed by partnerships between Pfizer and BioNTech (Comirnaty) and between the University of Oxford and AstraZeneca (AZD1222), while the third was developed by Moderna (MRNA-1273). As of 8 January 2021, there were four other COVID-19 vaccines on order for the programme, at varying stages of development.

Phase 1 of the rollout prioritises the most vulnerable, in a schedule primarily based on age. The delivery plan was adjusted on 30 December 2020, delaying second doses so that more people could receive their first dose. A preliminary target – giving everyone in the top four priority groups their first dose by the middle of February 2021 – was announced on 4 January 2021.

As of 31 January 2021: 9,296,367 first doses and 494,209 second doses, of either the Oxford–AstraZeneca or the Pfizer–BioNTech vaccine, had been administered across the UK.

Vaccination sites include GP practices, care homes and pharmacies, as well as hospitals. As of 29 January 2021, there were 1,462 vaccination sites operating in England. As of 7 January, there were 34 vaccination sites in Wales.[3][i] Additional sites, including large venues such as sports stadia, entered the programme from 11 January 2021, with seven mass vaccination centres opening in England initially and seven opening in Wales also.[3]

New guidance for allergy sufferers, antibody tests and the new variant of SARS-CoV-2 (Variant of Concern 202012/01) has been issued during the programme.

The programme also includes procurement of vaccines for British Overseas Territories and Crown Dependencies.[4][5][6]

Progress, as of 31 January 2021, with daily change
Home nation Doses administered per 100 people
 United Kingdom
14.66(+0.48)
 England
15.18(+0.52)
 Scotland
10.68(+0.18)
 Wales
13.23(+0.41)
 Northern Ireland
13.01(+0.40)

From official vaccination[2] and 2019 ONS[7][8][9][10] data.
(Doses may not equate to no. people if more than one dose received.)


Background[edit]

Responsibility for COVID-19 vaccine deployment[edit]

On 28 November 2020 the new role of Parliamentary Under-Secretary of State for COVID-19 Vaccine Deployment was set up by the UK government, with Nadhim Zahawi the first to take office.[11]

Vaccines on order[edit]

There are several COVID-19 vaccines at various stages of development around the world. As of 1 February 2021 the British government had placed orders for a combined total of 407 million doses across 7 different vaccines.[12][13][14] This does not equate to the number of people that can be immunised as some vaccines require more than one dose. The breakdown of the vaccines being considered for the vaccination programme is as follows:[15]

Vaccine Progress Doses ordered Approval Deployment
Pfizer–BioNTech phase III clinical trials 40 million Green check.svg 2 December 2020 Green check.svg 8 December 2020
Oxford–AstraZeneca phase III clinical trials 100 million Green check.svg 30 December 2020[16] Green check.svg 4 January 2021[17]
Moderna phase III clinical trials 17 million[13] Green check.svg 8 January 2021[13] Pending
Novavax phase III clinical trials 60 million Pending Pending
Valneva phase I/II clinical trials 100 million[14] Pending Pending
GSK/Sanofi Pasteur phase I/II clinical trials 60 million Pending Pending
Janssen phase III clinical trials 30 million Pending Pending

History[edit]

Regulatory approvals[edit]

On 2 December 2020, the UK became the first country to give approval for use of the Pfizer–BioNTech vaccine,[18][19] later branded as Comirnaty.[20] This was in the form of a temporary authorisation given by the Medicines and Healthcare products Regulatory Agency (MHRA) under Regulation 174 of the Human Medicines Regulations 2012.[21] Regulatory approval is reserved under the devolution settlement. The first batch arrived in the UK the next day and was initially stored at an undisclosed central hub before being distributed to hospital vaccination centres across the country.[22]

On 30 December 2020, the UK also became the first country to approve the Oxford/AstraZeneca vaccine.[16]

On 8 January 2021, the Moderna vaccine was approved as the third vaccine to enter the programme.[13]

On 28 January 2021, the results of the Novavax vaccine trials, which were undertaken in the UK and in South Africa, showed it was 95.6% effective against the original SARS-CoV-2 strains and 85.6% against the Variant of Concern 202012/01, then prevalent in the UK. The company stated it had begun the process of requesting clearance for use in the UK.[23] The Novavax vaccine was the first to be tested in clinical trials for efficacy against the UK's prevailing Variant of Concern 202012/01.[24] In clinical trial subjects without HIV infections, the vaccine was also 60% effective against the 501.V2 variant, a SARS-CoV-2 strain first detected in South Africa.[24]

Timeline[edit]

On 8 December 2020, Margaret Keenan, 90, became the first person in the world (outside trials) to receive the Pfizer–BioNTech vaccine, as the rollout of vaccinations began.[25] William Shakespeare, 81, from Warwickshire became the second person, and the first man, to be vaccinated.[26] Both vaccinations took place at University Hospital Coventry.

On 4 January 2021, Brian Pinker 82, became the first person (outside trials) to receive the Oxford–AstraZeneca vaccine. The vaccination took place at the Churchill Hospital, Oxford.[17] England Health Secretary, Matt Hancock said this was a "pivotal moment" in the programme as this vaccine was easier to transport and store, requiring only ordinary fridge temperatures. Six hospitals in England began the Oxford vaccine rollout using the first batch of around 530,000 doses.[27]

The Queen, 94, and Prince Philip, 99, received their vaccinations within their Windsor Castle residence on 9 January 2021.[28] Prince William cited their example, a week later, to encourage everyone to take up the vaccine[29] after hearing that a degree of vaccine hesitancy had set in.

The rollout to the over 70s and clinically extremely vulnerable began on 18 January 2021,[30] representing the fourth priority group and the final group needed to complete the government's initial 15 February target.[31] The Prime Minister, Boris Johnson was quoted as saying this was a "significant milestone".[30]

Emerging guidance[edit]

On 9 December 2020, the MHRA issued updated guidance, after two cases of anaphylaxis and another case of a possible allergic reaction following the vaccination. In the statement, June Raine, MHRA Chief Executive said:[32]

Any person with a history of anaphylaxis to a vaccine, medicine or food should not receive the Pfizer/BioNTech vaccine. A second dose should not be given to anyone who has experienced anaphylaxis following administration of the first dose of this vaccine.

Raine went on to say that such side effects have been known to happen with any vaccine but are "very rare". She continued to confirm that existing appointments should not be cancelled but people with a history of serious allergies should discuss this beforehand. Furthermore, she expressed confidence in the safety, assessment and monitoring of the vaccine. Guidance was given that vaccine recipients should be monitored for at least 15 minutes after vaccination and centres must be prepared for such events including the availability of an anaphylaxis pack.[32] The two people affected were quickly treated and recovered well.[32]

The Department of Health and Social Care confirm that although the vaccine triggers the creation of antibodies, vaccination does not affect the result of an antibody test to detect whether someone has previously contracted the virus. This is because there are differences between the antibodies triggered and those being tested for.[33]

As of 20 December 2020, Public Health England say there is "no evidence" to suggest that the recently identified Variant of Concern 202012/01 (a new variant of SARS-CoV-2) would be resistant to the Pfizer–BioNTech vaccine currently being used in the programme, and people should still be protected.[34] Further laboratory work is still being prioritised to increase current understanding of this.

Organisations involved[edit]

In the months before approval of the first vaccine, the Joint Committee on Vaccination and Immunisation (an independent group of experts) gave advice to the Vaccine Taskforce on the groups of people that should be prioritised for vaccination.[35][36] The taskforce was formed in May 2020 to lead efforts to develop, manufacture and procure vaccines for the UK and globally,[37] and was led until the end of 2020 by biotech venture capital manager Kate Bingham.[38]

As with other licensed vaccines, the National Institute for Biological Standards and Control (part of the MHRA) reviews the production process and the manufacturer's quality control, and tests each batch of vaccine.[39]

Rollout schedule[edit]

"I think the UK one-dose strategy is absolutely the right way to go, at least for our vaccine. I cannot comment about the Pfizer vaccine, whose studies are for a three-week interval."

"The efficacy of one dose is sufficient: 100 percent protection against severe disease and hospitalisation, and 71-73 percent of efficacy overall. The second dose is needed for long term protection."

— Pascal Soriot, AstraZeneca's CEO, 26th January 2021.[40]

Delivery plan[edit]

During the rollout of the Pfizer–BioNTech vaccine first doses, the UK government announced on 30 December 2020 that future deployment would focus on that initial dose, rather than giving the required two doses as quickly as possible. The announcement of this plan coincided with the approval of the Oxford–AstraZeneca vaccine, and so represents the strategy to rollout the two vaccines. The government stated that prioritising the first dose was on advice from the Joint Committee on Vaccination and Immunisation (JCVI) and further assured that everyone would still receive their second dose within 12 weeks of their first.[16] Despite this, Margaret Keenan, who was the first person outside of trials to receive a dose of the Pfizer–BioNTech vaccine, returned to hospital on 29 December 2020 for her follow-up injection. This was exactly three-weeks after her first, in accordance with the original plan until the announcement of the new strategy. By receiving her second dose, Keenan has completed the vaccination process.[41]

The new plan to increase the gap between first and second doses from 3 to 12 weeks, was criticised as "unfair" by the British Medical Association (BMA) on 31 December 2020, as appointments booked for 4 January 2021 or later would have to be rescheduled.[42] In response, all four Chief Medical Officers (CMO), plus England's Deputy CMO Jonathan Van-Tam, signed an open letter explaining the policy shift.[43] They said by prioritising first doses, more people would have substantial protection faster, and the second dose adds relatively minor additional protection in the short term. They went on to say that for every 1,000 people given the second 'booster' dose, 1,000 new people would not be able to have up to 70% protection and would instead remain totally unprotected.

Delivery targets[edit]

During his address to England on 4 January 2021, UK Prime Minister Boris Johnson indicated a preliminary target for the vaccination programme. He said:[31]

By the middle of February, if things go well and with a fair wind in our sails, we expect to have offered the first vaccine dose to everyone in the four top priority groups identified by the Joint Committee on Vaccination and Immunisation.

He went on to confirm this would include all elderly residents of care homes and indeed everyone over the age of 70, as well as all frontline health and social care workers, and all those who are "clinically extremely vulnerable".

Vaughan Gething, Health Minister for Wales, matched England's targets by announcing that all people in groups 1-4 would be offered a first dose by mid February.[44]

A vaccination plan was published by the Scottish Government on 14 January.[45] Part of this plan, subsequently withdrawn after objections from central government, projected the numbers of doses of vaccines delivered weekly to Scotland from the British Government until May, estimating that by mid-March there would be enough doses there to supply every person in the priority groups with their first doses, and enough doses by July to supply every adult with both doses.[46] Extrapolating from these figures, Sky News estimated that supply for the UK overall would be sufficient to meet the British Government's aim of immunising all 15 million priority individuals in the country by mid-February, and vaccinating all adults in Britain with their first dose by mid-July.[46]

Vaccine priority groups[edit]

Phase 1[edit]

The JCVI advised the governments on how to prioritise the rollout. The top priority for the programme was to prevent deaths and to ensure that the National Health Service (NHS) would not be overwhelmed, and as older people are more at risk of hospitalisation or death from COVID-19, prioritisation was primarily based on age.[47]

The table shows the priority groups for the first phase of the roll-out.[47] An estimate of the number of people in each group in the United Kingdom is also shown,[48] but should be read with care as people who fall into more than one group are counted more than once.

Order Priority group Number eligible (estimated)[48]
1 residents in a care home for older adults and their carers 1.1m
2 all those 80 years of age and over, and frontline health and social care workers 5.1m
3 all those 75 years of age and over 2.3m
4 all those 70 years of age and over, and clinically extremely vulnerable individuals 3.3m
5 all those 65 years of age and over 3.4m
6 all those aged 16 years to 64 years with underlying health conditions which put them at higher risk of serious disease and mortality 2.2m
7 all those 60 years of age and over 3.8m
8 all those 55 years of age and over 4.4m
9 all those 50 years of age and over 4.7m

"Clinically extremely vulnerable" is defined as:[49]

  • solid organ transplant recipients
  • people with specific cancers:
    • people with cancer who are undergoing active chemotherapy
    • people with lung cancer who are undergoing radical radiotherapy
    • people with cancers of the blood or bone marrow such as leukaemia, lymphoma or myeloma who are at any stage of treatment
    • people having immunotherapy or other continuing antibody treatments for cancer
    • people having other targeted cancer treatments that can affect the immune system, such as protein kinase inhibitors or PARP inhibitors
    • people who have had bone marrow or stem cell transplants in the last 6 months or who are still taking immunosuppression drugs
  • people with severe respiratory conditions including all cystic fibrosis, severe asthma and severe chronic obstructive pulmonary disease (COPD)
  • people with rare diseases that significantly increase the risk of infections (such as severe combined immunodeficiency (SCID), homozygous sickle cell disease)
  • people on immunosuppression therapies sufficient to significantly increase risk of infection
  • people with spleen problems, e.g. splenectomy (spleen removal)
  • adults with Down's syndrome
  • adults on dialysis or with chronic kidney disease (stage 5)
  • other people who have also been classed as clinically extremely vulnerable, based on clinical judgement and an assessment of their needs.

Women who are pregnant and children under 16 are not defined as clinically extremely vulnerable for the purpose of the vaccination programme.[47]

Polish group Omni Calculator developed a tool which estimates when individuals will receive the vaccine, based on age, employment, and health status.[50]

Phase 2[edit]

Whilst further details are still subject to a final decision, as safety and effectiveness data comes in from the first phase, phase 2 vaccinations may prioritise those at increased risk of exposure to the virus due to their occupation. Such occupations could include:[47]

  • first responders
  • the military
  • those involved in the justice system
  • teachers
  • transport workers
  • public servants essential to the pandemic response.

Pregnant women and children under 16 could also be included at this stage, dependent upon further trials in these groups.[47]

Progress to date[edit]

By the end of the first full week of the programme, up to 15 December 2020, 137,897 people had been vaccinated with the first dose in the two-dose regimen: 108,000 in England, 7,897 in Wales, 4,000 in Northern Ireland and 18,000 in Scotland.[51][52]

By 5 January 2021, 1.3 million people across the UK had received their first dose of either the Pfizer or Oxford–AstraZeneca COVID-19 vaccine, which included more than 650,000 people over 80, representing around 23% of that age band in England.[53]

As of 31 January 2021, a cumulative total of 9,296,367 people had received the first dose: 8,082,355 in England; 221,809 in Northern Ireland; 575,897 in Scotland and 416,306 in Wales. In addition, a cumulative total of 494,209 people had received the second dose: 460,907 in England; 24,612 in Northern Ireland; 7,849 in Scotland and 841 in Wales.[2]

Government vaccination updates increased from weekly to daily, from 11 January 2021.[53]

Latest 24-hour new and cumulative doses, by dose type, as at 31 January 2021[2]
Latest DAILY figures  England  Northern Ireland  Scotland  Wales UK TOTAL
Date Dose New Cumulative New Cumulative New Cumulative New Cumulative New Cumulative
31 Jan 2021 1st 289,359 8,082,355 7,208 221,809 9,628 575,897 12,843 416,306 319,038 9,296,367
2nd 2,757 460,907 289 24,612 55 7,849 55 841 3,156 494,209
Total 292,116 8,543,262 7,497 246,421 9,683 583,746 12,898 417,147 322,194 9,790,576

Scotland and Wales only report their data on weekdays.[2]


Weekly new and cumulative doses, by dose type, as at each week-ending date[2]
Previous WEEKLY figures  England  Northern Ireland  Scotland  Wales UK TOTAL
Date Dose New Cumulative New Cumulative New Cumulative New Cumulative New Cumulative
13 Dec 2020 1st not available[ii] not available[ii] 3,623 3,623 18,967 18,967 8,181 8,181 30,771 30,771
20 Dec 2020 1st 570,199 570,199 12,445 16,068 40,865 59,832 15,394 23,575 638,903 669,674
27 Dec 2020 1st 265,276 835,475 14,948 31,016 34,341 94,173 12,377 35,952 326,942 996,616
03 Jan 2021 1st 326,267 1,161,742 9,669 40,685 21,316 115,489 13,979 49,931 371,231 1,367,847
2nd 20,467 20,467 1,271 1,271 44 44 26 26 21,808 21,808
Total 346,734 1,182,209 10,940 41,956 21,360 115,533 14,005 49,957 393,039 1,389,655
10 Jan 2021 1st 940,927 2,102,669 38,395 79,080 50,920 166,409 40,767 90,698 1,071,009 2,438,856
2nd 376,807 397,274 12,287 13,558 2,789 2,833 59 85 391,942 413,750
Total 1,317,734 2,499,943 50,682 92,638 53,709 169,242 40,826 90,783 1,462,951 2,852,606
17 Jan 2021 1st 1,573,588 3,676,257 46,637 125,717 103,753 270,162 66,689 157,387 1,790,667 4,229,523
2nd 38,376 435,650 8,768 22,326 1,107 3,940 113 198 48,364 462,114
Total 1,611,964 4,111,907 55,405 148,043 104,860 274,102 66,802 157,585 1,839,031 4,691,637
24 Jan 2021 1st 2,115,902 5,792,159 33,925 159,642 145,107 415,269 120,303 277,690 2,415,237 6,644,760
2nd 4,775 440,425 387 22,713 2,000 5,940 358 556 7,520 469,634
Total 2,120,677 6,232,584 34,312 182,355 147,107 421,209 120,661 278,246 2,422,757 7,114,394

Vaccination centres[edit]

Marshalling for COVID-19 vaccines at a medical centre in Wetherby, West Yorkshire.

More than 70 sites across the UK were in operation at the end of the programme's first full week (15 December 2020). Whilst hospitals formed the centres initially, GP-led centres also started later in that week.[54]

Care home locations in England entered the programme on Wednesday 16 December. "Hundreds" of residents received the first dose in seven care homes in Slough, Aintree, Herne Bay, Thanet, Chalfont St Peter, Droitwich and Cheltenham.[55] Larger care homes (50 to 70 beds) were to be prioritised.[55]

The Chelsea Pensioners received their first dose at the Royal Hospital Chelsea on 23 December.[56]

Large venues such as sports stadia and exhibition centres started to be used as mass vaccination centres from 11 January 2021,[53] with seven such centres opening in England at Millennium Point, Birmingham; Ashton Gate Stadium, Bristol; ExCeL London; Manchester Tennis and Football Centre; Centre for Life, Newcastle; Robertson House, Stevenage; and Epsom Downs Racecourse, Surrey.[57]

High street pharmacies in England started to administer the vaccine from 14 January 2021, with 6 chosen for the roll out initially.[58]

Places of worship also started to be used as large vaccination centres, with Salisbury Cathedral[59] and Lichfield Cathedral[60] among the first to make provisions from 15 January 2021; with the Al-Abbas Islamic Centre in Balsall Heath, Birmingham becoming the first mosque to offer the service on 21 January 2021.[61]

Locations[edit]

As of 29 January 2021, there were a total of 1,462 vaccination sites operating in England,[i] an increase of 121 since 22 January. These were made up as follows:[62]

Number of vaccination sites in England, by region and type, as at 29 January 2021[62]
Region Hospital hubs Local vaccination services Mass vaccination centres Pharmacies Totals
East of England 23 137 8 168
London 54 108 6 168
Midlands 39 182 11 232
North East and Yorkshire 37 176 5 218
North West 43 137 5 185
South East 39 178 6 223
South West 19 110 9 138
Region not specified 130 130
Grand Total 254 1,028 50 130 1,462

  • Vaccination site locations in Wales, as at 15 January 2021

  • Vaccination site locations in England, as at 29 January 2021

  • Vaccination site locations in Scotland, as at 14 January 2021

See also[edit]

Notes[edit]

  1. ^ a b As of the stated date, location data for Scotland, Wales and Northern Ireland has not been published by the respective devolved authorities.
  2. ^ a b England vaccination uptake data not published until 15 December 2020, so carried forward to next week ending

References[edit]

  1. ^ "Statistical work areas - COVID-19 Vaccinations". NHS.uk. NHS England. Retrieved 29 January 2021.
  2. ^ a b c d e f "People who have received vaccinations, by nation". Coronavirus (COVID-19) in the UK. GOV.UK. Retrieved 1 February 2020.
  3. ^ a b Vaccination Strategy for Wales (PDF). Welsh Government. p. 10.
  4. ^ https://www.miamiherald.com/news/nation-world/world/americas/haiti/article248354030.html
  5. ^ https://commonslibrary.parliament.uk/research-briefings/cbp-9021/
  6. ^ https://www.gov.je/news/2020/pages/CMPressConferenceSpeech.aspx
  7. ^ UK Census (2011). "Local Area Report – England (2092957699)". Nomis. Office for National Statistics.
  8. ^ UK Census (2011). "Local Area Report – Scotland (2013265931)". Nomis. Office for National Statistics.
  9. ^ UK Census (2011). "Local Area Report – Wales (2013265930)". Nomis. Office for National Statistics.
  10. ^ UK Census (2011). "Local Area Report – Northern Ireland (2013265932)". Nomis. Office for National Statistics.
  11. ^ "Ministerial role Parliamentary Under Secretary of State (Minister for COVID Vaccine Deployment)". Gov.uk. Department of Health and Social Care. 28 November 2020. Retrieved 16 December 2020.
  12. ^ "An update on the coronavirus vaccine, 2 December 2020". Gov.uk. Department of Health and Social Care and The Rt Hon Matt Hancock MP. 2 December 2020. Retrieved 16 December 2020.
  13. ^ a b c d "Third Covid vaccine approved in the UK". BBC. BBC News. 8 January 2021. Retrieved 8 January 2021.
  14. ^ a b "UK government secures additional 40 million doses of Valneva vaccine". Gov.uk. Department of Health and Social Care. 1 February 2021. Retrieved 2 February 2021.
  15. ^ "UK government secures additional 2 million doses of Moderna COVID-19 vaccine". Gov.uk. Department for Business, Energy & Industrial Strategy, Department of Health and Social Care, The Rt Hon Alok Sharma MP, and The Rt Hon Matt Hancock MP. 29 November 2020. Retrieved 16 December 2020.
  16. ^ a b c "Oxford University/AstraZeneca vaccine authorised by UK medicines regulator". Gov.uk. Department of Health and Social Care. 30 December 2020. Retrieved 30 December 2020.
  17. ^ a b "Covid: Oxford vaccine rollout under way across the UK". BBC News. BBC. 4 January 2021. Retrieved 4 January 2021.
  18. ^ "UK medicines regulator gives approval for first UK COVID-19 vaccine". Gov.uk. Medicines and Healthcare products Regulatory Agency. 2 December 2020. Retrieved 16 December 2020.
  19. ^ "Covid-19: Pfizer/BioNTech vaccine judged safe for use in UK". 2 December 2020. Retrieved 2 December 2020 – via www.bbc.co.uk.
  20. ^ "Comirnaty EPAR". European Medicines Agency (EMA). Retrieved 17 January 2021.
  21. ^ "Decision: Conditions of Authorisation for Pfizer/BioNTech COVID-19 vaccine". Gov.uk. Medicines and Healthcare products Regulatory Agency. 16 December 2020. Retrieved 16 December 2020.
  22. ^ "Covid: First batch of vaccines arrives in the UK". 3 December 2020. Retrieved 3 December 2020 – via www.bbc.co.uk.
  23. ^ "Novavax Vaccine Is 89% Effective Against Covid-19 in U.K. Study". 28 January 2021. Retrieved 28 January 2021.
  24. ^ a b "Covid-19: Novavax vaccine shows 89% efficacy in UK trials". BBC News. 29 January 2021. Retrieved 29 January 2021.
  25. ^ "First patient receives Pfizer Covid-19 vaccine". 8 December 2020. Retrieved 16 December 2020 – via www.bbc.co.uk.
  26. ^ "Covid-19 vaccine: Patient William Shakespeare second to get vaccination". 8 December 2020. Retrieved 16 December 2020 – via www.bbc.co.uk.
  27. ^ "'Pivotal moment' as Britain set to roll out AstraZeneca vaccine". Reuters. 4 January 2021. Retrieved 4 January 2021.
  28. ^ "Covid-19: Queen and Prince Philip receive vaccinations". BBC News. BBC. 9 January 2021. Retrieved 17 January 2021.
  29. ^ Cope, Emily. "Prince William urges the public to follow the queen's example and get COVID jab". The Independent (16 January 2021). Independent Digital News & Media Ltd. Retrieved 17 January 2021.
  30. ^ a b "Covid-19: Vaccination rollout begins for over-70s in England". BBC News. BBC. 17 January 2021. Retrieved 17 January 2021.
  31. ^ a b "Prime Minister's address to the nation: 4 January 2021". Gov.uk. Prime Minister's Office, 10 Downing Street and The Rt Hon Boris Johnson MP. 4 January 2021. Retrieved 4 January 2021.
  32. ^ a b c "Confirmation of guidance to vaccination centres on managing allergic reactions following COVID-19 vaccination with the Pfizer/BioNTech vaccine". Gov.uk. Medicines and Healthcare products Regulatory Agency. 9 December 2020. Retrieved 18 December 2020.
  33. ^ "Coronavirus (COVID-19): antibody testing". Gov.uk. Department of Health & Social Care. 17 December 2020. Retrieved 18 December 2020.
  34. ^ "COVID-19 (SARS-CoV-2): information about the new virus variant". Gov.uk. Public Health England. 20 December 2020. Retrieved 21 December 2020.
  35. ^ "Covid-19: Most vulnerable 'could get vaccine by Christmas'". BBC News. 17 October 2020. Retrieved 21 December 2020.
  36. ^ "Priority groups for coronavirus (COVID-19) vaccination: advice from the JCVI". GOV.UK. Department of Health and Social Care. 2 December 2020. Retrieved 21 December 2020.
  37. ^ Bingham, Kate (27 October 2020). "The UK Government's Vaccine Taskforce: strategy for protecting the UK and the world". The Lancet. doi:10.1016/S0140-6736(20)32175-9. Retrieved 16 January 2021.
  38. ^ "Covid-19: Vaccination targets could be exceeded, says Kate Bingham". BBC News. 8 January 2021. Retrieved 16 January 2021.
  39. ^ "Independent batch release testing of COVID-19 (coronavirus) vaccines by the NIBSC". GOV.UK. Medicines and Healthcare products Regulatory Agency. 22 December 2020. Retrieved 23 December 2020.
  40. ^ "Pascal Soriot: "There are a lot of emotions on vaccines in EU. But it's complicated"". la Repubblica. 27 January 2021.
  41. ^ "Covid-19: First vaccine patient has her second jab". 29 December 2020. Retrieved 29 December 2020 – via www.bbc.co.uk.
  42. ^ Mahase, Elisabeth (31 December 2020). "Covid-19: Order to reschedule and delay second vaccine dose is "totally unfair," says BMA". British Medical Journal. doi:10.1136/bmj.m4978. Retrieved 3 January 2021.
  43. ^ "Letter to the profession from the UK Chief Medical Officers regarding the UK COVID-19 vaccination programmes". Gov.uk. Department of Health and Social Care. 31 December 2020. Retrieved 3 January 2020.
  44. ^ Hayward, Will (11 January 2021). "Wales sets three targets for coronavirus vaccine rollout". WalesOnline. Retrieved 12 January 2021.
  45. ^ "Coronavirus (COVID-19): vaccine deployment plan 2021 - gov.scot". www.gov.scot. Retrieved 16 January 2021.
  46. ^ a b Manthorpe, Rowland (16 January 2021). "COVID-19: Every UK adult could be vaccinated by mid-July - if these figures are anything to go by". Sky News. Sky. Retrieved 16 January 2021.
  47. ^ a b c d e "Joint Committee on Vaccination and Immunisation: advice on priority groups for COVID-19 vaccination". GOV.UK. Department of Health & Social Care. 30 December 2020. Retrieved 7 January 2021.
  48. ^ a b "The priority list for the Pfizer and Oxford vaccines - and how they will be rolled out". The Telegraph. 31 December 2020. ISSN 0307-1235. Retrieved 31 December 2020.
  49. ^ "Guidance on shielding and protecting people who are clinically extremely vulnerable from COVID-19". Gov.uk. Department of Health & Social Care and Public Health England. 14 December 2020. Retrieved 16 December 2020.
  50. ^ Sommerlad, Joe (4 January 2021). "When will I get the Covid vaccine? Online calculator estimates your place in the queue". The Independent. Retrieved 4 January 2021.
  51. ^ Lay, Kat; Blakely, Rhys (17 December 2020). "138,000 vaccinated in a week". The Times (73, 345). p. 5. ISSN 0140-0460.
  52. ^ Parsons, Rob (17 December 2020). "Minister hails 'good start to vaccine roll-out'". The Yorkshire Post. p. 5. ISSN 0963-1496.
  53. ^ a b c "Prime Minister's statement on coronavirus (COVID-19): 5 January 2021". Gov.uk. Prime Minister's Office, 10 Downing Street and The Rt Hon Boris Johnson MP. 5 January 2021. Retrieved 6 January 2021.
  54. ^ "More than 137,000 people in UK receive first dose of COVID vaccine in one week". Gov.uk. Department of Health & Social Care. 16 December 2020. Retrieved 17 December 2020.
  55. ^ a b "Over 600,000 people get first dose of Pfizer/BioNTech vaccine". Gov.uk. Department of Health and Social Care. 24 December 2020. Retrieved 26 December 2020.
  56. ^ "Covid vaccine: Chelsea Pensioners receive jab 'gift'". BBC News. BBC. 23 December 2020. Retrieved 26 December 2020.
  57. ^ "Covid: Mass vaccination centres to open in England". BBC News. BBC. 11 January 2021. Retrieved 11 January 2021.
  58. ^ "Covid-19: High Street chemists start vaccinations in England". BBC News. BBC. 14 January 2021. Retrieved 14 January 2021.
  59. ^ "RAF veteran receives Covid jab at Salisbury Cathedral". BBC News. BBC. 16 January 2021. Retrieved 17 January 2021.
  60. ^ "Covid-19: Lichfield Cathedral turned into vaccination centre". BBC News. 15 January 2021. Retrieved 16 January 2021.
  61. ^ "Birmingham mosque becomes UK's first to offer Covid vaccine". BBC News. BBC. 21 January 2021. Retrieved 24 January 2021.
  62. ^ a b "Vaccination sites". NHS.uk. NHS England. Retrieved 2 February 2021.

External links[edit]

Retrieved from "https://en.wikipedia.org/w/index.php?title=COVID-19_vaccination_programme_in_the_United_Kingdom&oldid=1004625885"